Erik Lium, PhD, is the President of Mount Sinai Innovation Partners (MSIP) and Chief Commercial Innovation Officer of the Mount Sinai Health System. Dr. Lium is responsible for advancing Mount Sinai’s research, instruction, and public service missions through strategic research partnerships with industry, the management, transfer and commercialization of Mount Sinai technologies, and fostering the development of start-ups to advance promising early-stage technologies. Under Dr. Lium’s leadership and through Mount Sinai’s expansive network of industry partnerships, and vast array of innovators in the fields of drugs, devices, diagnostics, and digital health, Mount Sinai has become a globally recognized leader in technology commercialization. Under his leadership, there has been a significant increase in the number of products brought to the patient population, as well as in Mount Sinai’s startup activity surrounding unmet needs in healthcare. Dr. Lium joined Mount Sinai as Vice President of MSIP in 2014 and was named Executive Vice President in 2018. Earlier, he held positions at the University of California, San Francisco (UCSF), including Assistant Vice Chancellor of Innovation, Technology and Alliances; UCSF Principal Investigator for the Bay Area National Science Foundation I-Corps node; and Assistant Vice Chancellor of Research. He also served as Founder and President of LabVelocity Inc., information services company focused on accelerating research and development in the life sciences. Dr. Lium earned his PhD in Cellular, Molecular and Biophysical Studies at Columbia University and pursued post-doctoral training at UCSF.